Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Thomas Haegin who wrote (917)	2/7/1998 1:23:00 AM
From: Tom Hua	Read Replies (2) \| Respond to of 2068

Thomas, I'm afraid OXHP will pull back next week when people have come to realize that Franklin Mutual/Franklin resources (ie., Michael Price)'s investment in OXHP is part of the group's healthcare investment. It is a passive investment. Below are two 13Gs and one 13D recently filed by the Franklin Group. Form Date Company #of shares Percent of Type Filed (Million) outstanding 13D 1/7/98 Pacificare 1.5 ClA 9.9 13D 1/7/98 Pacificare 1.3 ClB 4.9 13G 2/4/98 Foundation Health 3.9 9.9 13G 2/5/98 Maxicare 1.8 9.9 According to the WSJ article, the Franklin Group/Michael Price also owns Mid-Atlantic, but I haven't found the filing. I think today's filing has no more significance than the filings on 2/4 and 2/5 for Foundation Health and Maxicare, and on 1/7 for Pacificare. The reason the stock moved, IMHO, is because of CNBC, which could have caused misunderstanding in investors that Price will step in to take control or force changes of Oxford. I think once people realize the fact, stock will retreat, probably as early as Monday. Regards, Tom